To Evaluate the analgesic efficacy of the anterior femoral cutaneous nerve block (AFCNB) combined with the adductor canal block (ACB) in patients undergoing unilateral total knee replacement (TKR) : A randomized controlled trial - Nil

Josemine Davis0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1.Adults aged 18 years and older undergoing unilateral TKR
•2.ASA classification I-III.
•3.Patients capable of providing informed consent or with consent provided by a legal guardian.
•4.Patients who can comprehend and cooperate with study procedures and pain assessment tools.

•1.Patients with contraindications or allergies to local anaesthetics used in nerve block procedures.
•2.Patients scheduled for emergency orthopaedic procedures.
•3.Patients with chronic opioid use or opioid tolerance.
•4.Patients with pre-existing neurological disorders that may affect pain perception.
•5.Patients with coagulopathies or those on anticoagulant therapy that cannot be temporarily stopped.
•6.Known allergies to components of the nerve block procedures.
•7.Patients with active infections or open wounds at the site of the nerve block.
•8.Pregnant or lactating women.
•9.Patients currently enrolled in other clinical trials or studies involving pain management techniques.

发起方

Josemine Davis